Systemic lupus erythematosus (SLE) is an autoimmune disease, in which the immune system that normally protects the body from invading microbes turns against the body's own cells. Researchers ...

SAPHNELO Consistently Reduces Systemic Lupus Erythematosus Disease Activity Regardless of Disease Duration and Prior Treatment. November 01, 2021 11:08 AM Eastern Daylight Time.

Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

Flare and Persistently Active Disease Are Common in Lupus Flare and persistently active disease are prevalent in a multinational cohort study of patients with systemic lupus erythematosus, with ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown etiology, representing significant diagnostic and therapeutic challenges. The disease is uncommon but not rare, with a ...

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

A new study finds the prevalence of developing celiac disease (CD) in people with systemic lupus erythematosus (SLE) is similar to the general population. CD is an autoimmune disease caused by the ...

Systemic lupus erythematosus (SLE) is characterized by autoantibody production, with anti-dsDNA antibodies (anti-dsDNA) being a key indicator for SLE diagnosis and disease monitoring. A new study ...

BEERSE, Belgium, October 23, 2018 /PRNewswire/ --Janssen presents one-year data from continued Phase 2 lupus study during plenary session at 2018 ...

It may seem like lupus and lung disease don’t have much in common. But around half of all people with systemic lupus erythematosus (SLE), the most common type of lupus, also deal with lung ...